# Limbach Holdings, Inc.: financial statements, quarterly

LMB · Nasdaq · CIK 1606163 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lmb.md) · [Financials](/companies/lmb/financials.md) · [Filings](/companies/lmb/filings.md) · [Insiders](/companies/lmb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lmb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [128](/filings/0001628280-24-045297.md) | [143 d](/filings/0001628280-26-013285.md) | [119](/filings/0001628280-25-022234.md) | [122](/filings/0001628280-25-037922.md) | [134](/filings/0001628280-25-049021.md) | [144 d](/filings/0001628280-26-013285.md) | [133](/filings/0001628280-26-030678.md) | [142](/filings/0001628280-26-052622.md) | [185](/filings/0001628280-25-049021.md) | [187 d](/filings/0001628280-26-013285.md) | [139](/filings/0001628280-26-030678.md) | [173](/filings/0001628280-26-052622.md) |
| Cost of revenue | $m | [96.5](/filings/0001628280-24-045297.md) | [109 d](/filings/0001628280-26-013285.md) | [87.9](/filings/0001628280-25-022234.md) | [88.7](/filings/0001628280-25-037922.md) | [97.8](/filings/0001628280-25-049021.md) | [100 d](/filings/0001628280-26-013285.md) | [96.4](/filings/0001628280-26-030678.md) | [102](/filings/0001628280-26-052622.md) | [140](/filings/0001628280-25-049021.md) | [139 d](/filings/0001628280-26-013285.md) | [108](/filings/0001628280-26-030678.md) | [136](/filings/0001628280-26-052622.md) |
| Gross profit | $m | [31.2](/filings/0001628280-24-045297.md) | [33.3 d](/filings/0001628280-26-013285.md) | [31.1](/filings/0001628280-25-022234.md) | [33.5](/filings/0001628280-25-037922.md) | [36.1](/filings/0001628280-25-049021.md) | [43.6 d](/filings/0001628280-26-013285.md) | [36.7](/filings/0001628280-26-030678.md) | [39.8](/filings/0001628280-26-052622.md) | [44.7](/filings/0001628280-25-049021.md) | [48.1 d](/filings/0001628280-26-013285.md) | [31.2](/filings/0001628280-26-030678.md) | [37.3](/filings/0001628280-26-052622.md) |
| Selling, general and administrative | $m | [21.0](/filings/0001628280-24-045297.md) | [25.0 d](/filings/0001628280-26-013285.md) | [22.9](/filings/0001628280-25-022234.md) | [23.2](/filings/0001628280-25-037922.md) | [23.7](/filings/0001628280-25-049021.md) | [27.4 d](/filings/0001628280-26-013285.md) | [26.5](/filings/0001628280-26-030678.md) | [26.6](/filings/0001628280-26-052622.md) | [28.3](/filings/0001628280-25-049021.md) | [28.0 d](/filings/0001628280-26-013285.md) | [28.1](/filings/0001628280-26-030678.md) | [28.1](/filings/0001628280-26-052622.md) |
| Operating income | $m | [9.8](/filings/0001628280-24-045297.md) | [7.3 d](/filings/0001628280-26-013285.md) | [6.5](/filings/0001628280-25-022234.md) | [8.2](/filings/0001628280-25-037922.md) | [10.9](/filings/0001628280-25-049021.md) | [13.0 d](/filings/0001628280-26-013285.md) | [7.9](/filings/0001628280-26-030678.md) | [10.6](/filings/0001628280-26-052622.md) | [13.3](/filings/0001628280-25-049021.md) | [17.6 d](/filings/0001628280-26-013285.md) | [1.1](/filings/0001628280-26-030678.md) | [7.3](/filings/0001628280-26-052622.md) |
| Interest expense | $m | [0.4](/filings/0001628280-24-045297.md) | [0.4 d](/filings/0001628280-24-010995.md) | [0.5](/filings/0001628280-25-022234.md) | [0.4](/filings/0001628280-25-037922.md) | [0.5](/filings/0001628280-25-049021.md) | [0.5 d](/filings/0001628280-26-013285.md) | [0.5](/filings/0001628280-26-030678.md) | [0.6](/filings/0001628280-26-052622.md) | [1.2](/filings/0001628280-25-049021.md) | [0.8 d](/filings/0001628280-26-013285.md) | [0.7](/filings/0001628280-26-030678.md) | [0.8](/filings/0001628280-26-052622.md) |
| Income tax | $m | [2.8](/filings/0001628280-24-045297.md) | [1.9 d](/filings/0001628280-26-013285.md) | [(0.3)](/filings/0001628280-25-022234.md) | [2.4](/filings/0001628280-25-037922.md) | [3.4](/filings/0001628280-25-049021.md) | [3.6 d](/filings/0001628280-26-013285.md) | [(2.2)](/filings/0001628280-26-030678.md) | [3.0](/filings/0001628280-26-052622.md) | [3.8](/filings/0001628280-25-049021.md) | [5.0 d](/filings/0001628280-26-013285.md) | [(3.7)](/filings/0001628280-26-030678.md) | [1.8](/filings/0001628280-26-052622.md) |
| Net income | $m | [7.2](/filings/0001628280-24-045297.md) | [5.2 d](/filings/0001628280-26-013285.md) | [7.6](/filings/0001628280-25-049021.md) | [6.0](/filings/0001628280-25-049021.md) | [7.5](/filings/0001628280-25-049021.md) | [9.8 d](/filings/0001628280-26-013285.md) | [10.2](/filings/0001628280-26-052622.md) | [7.8](/filings/0001628280-26-052622.md) | [8.8](/filings/0001628280-25-049021.md) | [12.3 d](/filings/0001628280-26-013285.md) | [4.4](/filings/0001628280-26-052622.md) | [4.7](/filings/0001628280-26-052622.md) |
| Diluted EPS | $ per share | [0.61](/filings/0001628280-24-045297.md) | not reported | [0.64](/filings/0001628280-25-022234.md) | [0.50](/filings/0001628280-25-037922.md) | [0.62](/filings/0001628280-25-049021.md) | not reported | [0.85](/filings/0001628280-26-030678.md) | [0.64](/filings/0001628280-26-052622.md) | [0.73](/filings/0001628280-25-049021.md) | not reported | [0.36](/filings/0001628280-26-030678.md) | [0.39](/filings/0001628280-26-052622.md) |
| Basic EPS | $ per share | [0.66](/filings/0001628280-24-045297.md) | not reported | [0.68](/filings/0001628280-25-022234.md) | [0.53](/filings/0001628280-25-037922.md) | [0.66](/filings/0001628280-25-049021.md) | not reported | [0.89](/filings/0001628280-26-030678.md) | [0.67](/filings/0001628280-26-052622.md) | [0.76](/filings/0001628280-25-049021.md) | not reported | [0.37](/filings/0001628280-26-030678.md) | [0.40](/filings/0001628280-26-052622.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [57.5](/filings/0001628280-23-037858.md) | [59.8](/filings/0001628280-25-011745.md) | [48.2](/filings/0001628280-24-021719.md) | [59.5](/filings/0001628280-24-035219.md) | [51.2](/filings/0001628280-24-045297.md) | [44.9](/filings/0001628280-26-013285.md) | [38.1](/filings/0001628280-25-022234.md) | [38.9](/filings/0001628280-25-037922.md) | [9.8](/filings/0001628280-25-049021.md) | [11.3](/filings/0001628280-26-052622.md) | [15.8](/filings/0001628280-26-030678.md) | [17.5](/filings/0001628280-26-052622.md) |
| Current assets | $m | [214](/filings/0001628280-23-037858.md) | [217](/filings/0001628280-25-011745.md) | [199](/filings/0001628280-24-021719.md) | [213](/filings/0001628280-24-035219.md) | [217](/filings/0001628280-24-045297.md) | [220](/filings/0001628280-26-013285.md) | [205](/filings/0001628280-25-022234.md) | [209](/filings/0001628280-25-037922.md) | [217](/filings/0001628280-25-049021.md) | [195](/filings/0001628280-26-052622.md) | [192](/filings/0001628280-26-030678.md) | [223](/filings/0001628280-26-052622.md) |
| Total assets | $m | [285](/filings/0001628280-23-037858.md) | [304](/filings/0001628280-25-011745.md) | [289](/filings/0001628280-24-021719.md) | [304](/filings/0001628280-24-035219.md) | [324](/filings/0001628280-24-045297.md) | [352](/filings/0001628280-26-013285.md) | [336](/filings/0001628280-25-022234.md) | [343](/filings/0001628280-25-037922.md) | [409](/filings/0001628280-25-049021.md) | [381](/filings/0001628280-26-052622.md) | [377](/filings/0001628280-26-030678.md) | [404](/filings/0001628280-26-052622.md) |
| Current liabilities | $m | [137](/filings/0001628280-23-037858.md) | [145](/filings/0001628280-25-011745.md) | [124](/filings/0001628280-24-021719.md) | [131](/filings/0001628280-24-035219.md) | [138](/filings/0001628280-24-045297.md) | [151](/filings/0001628280-26-013285.md) | [132](/filings/0001628280-25-022234.md) | [123](/filings/0001628280-25-037922.md) | [151](/filings/0001628280-25-049021.md) | [135](/filings/0001628280-26-052622.md) | [112](/filings/0001628280-26-030678.md) | [150](/filings/0001628280-26-052622.md) |
| Total liabilities | $m | [171](/filings/0001628280-23-037858.md) | [184](/filings/0001628280-25-011745.md) | [164](/filings/0001628280-24-021719.md) | [171](/filings/0001628280-24-035219.md) | [182](/filings/0001628280-24-045297.md) | [199](/filings/0001628280-26-013285.md) | [175](/filings/0001628280-25-022234.md) | [172](/filings/0001628280-25-037922.md) | [228](/filings/0001628280-25-049021.md) | [185](/filings/0001628280-26-052622.md) | [181](/filings/0001628280-26-030678.md) | [201](/filings/0001628280-26-052622.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [2.5](/filings/0001628280-23-037858.md) | [2.7](/filings/0001628280-25-011745.md) | [2.5](/filings/0001628280-24-021719.md) | [2.5](/filings/0001628280-24-035219.md) | [2.6](/filings/0001628280-24-045297.md) | [3.3](/filings/0001628280-26-013285.md) | [3.4](/filings/0001628280-25-022234.md) | [4.4](/filings/0001628280-25-037922.md) | [5.3](/filings/0001628280-25-049021.md) | [5.0](/filings/0001628280-26-052622.md) | [4.9](/filings/0001628280-26-030678.md) | [4.9](/filings/0001628280-26-052622.md) |
| Shareholders' equity | $m | [114](/filings/0001628280-24-045297.md) | [121](/filings/0001628280-26-013285.md) | [126](/filings/0001628280-25-049021.md) | [133](/filings/0001628280-25-049021.md) | [142](/filings/0001628280-25-049021.md) | [153](/filings/0001628280-26-052622.md) | [161](/filings/0001628280-26-052622.md) | [171](/filings/0001628280-26-052622.md) | [182](/filings/0001628280-25-049021.md) | [196](/filings/0001628280-26-052622.md) | [196](/filings/0001628280-26-052622.md) | [203](/filings/0001628280-26-052622.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [17.2 d](/filings/0001628280-24-045297.md) | [13.9 d](/filings/0001628280-26-013285.md) | [(3.9)](/filings/0001628280-25-022234.md) | [16.5 d](/filings/0001628280-25-037922.md) | [4.9 d](/filings/0001628280-25-049021.md) | [19.3 d](/filings/0001628280-26-013285.md) | [2.2](/filings/0001628280-26-030678.md) | [2.0 d](/filings/0001628280-26-052622.md) | [13.3 d](/filings/0001628280-25-049021.md) | [28.1 d](/filings/0001628280-26-013285.md) | [(7.8)](/filings/0001628280-26-030678.md) | [18.7 d](/filings/0001628280-26-052622.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001628280-24-045297.md) | [0.5 d](/filings/0001628280-26-013285.md) | [2.5](/filings/0001628280-25-022234.md) | [3.3 d](/filings/0001628280-25-037922.md) | [0.4 d](/filings/0001628280-25-049021.md) | [1.3 d](/filings/0001628280-26-013285.md) | [2.2](/filings/0001628280-26-030678.md) | [0.8 d](/filings/0001628280-26-052622.md) | [0.5 d](/filings/0001628280-25-049021.md) | [0.3 d](/filings/0001628280-26-013285.md) | [0.4](/filings/0001628280-26-030678.md) | [0.6 d](/filings/0001628280-26-052622.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.7](/filings/0001628280-23-037858.md) | [11.0](/filings/0001628280-24-021719.md) | [11.5](/filings/0001628280-24-035219.md) | [11.8](/filings/0001628280-24-045297.md) | [11.9](/filings/0001628280-25-022234.md) | [12.0](/filings/0001628280-25-037922.md) | [12.0](/filings/0001628280-25-049021.md) | [12.1](/filings/0001628280-26-030678.md) | [12.1](/filings/0001628280-26-052622.md) | [12.1](/filings/0001628280-25-049021.md) | [12.1](/filings/0001628280-26-030678.md) | [12.0](/filings/0001628280-26-052622.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,924,993 at 2026-08-03, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052622.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.